emetine has been researched along with Carcinoma, Bronchogenic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Street, EW | 1 |
| Hyde, KR; Marsh, K; Perry, W | 1 |
| Coltman, CA; Panettiere, F | 1 |
3 other study(ies) available for emetine and Carcinoma, Bronchogenic
| Article | Year |
|---|---|
Cyclophosphamide plus emetine in lung cancer.
Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Combinations; Emetine; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiography; Remission, Spontaneous | 1972 |
Cyclophosphamide plus emetine in lung cancer.
Topics: Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Emetine; Humans; Lung Neoplasms; Male; Middle Aged | 1972 |
Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Colonic Neoplasms; Diarrhea; Electrocardiography; Emetine; Female; Humans; Injections, Intravenous; Laryngeal Neoplasms; Leukemia, Lymphoid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Myositis; Nausea; Tachycardia; Thyroid Neoplasms; Tracheal Neoplasms; Urinary Bladder Neoplasms | 1971 |